High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis

High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis

Abstract Background High-dose proton beam therapy (PBT) uses excellent dose concentricity based on the unique characteristic termed the Bragg peak. PBT is a highly feasible treatment option that improves survival in select patients with newly diagnosed glioblastoma (GBM). However, selection bias rem...

Full description

Bibliographic Details
Main Authors: Masahide Matsuda, Masashi Mizumoto, Hidehiro Kohzuki, Narushi Sugii, Hideyuki Sakurai, Eiichi Ishikawa
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Radiation Oncology
Subjects:
Proton beam therapy
Glioblastoma
Treatment outcome
Propensity score matching
Online Access:https://doi.org/10.1186/s13014-023-02236-1

Internet

https://doi.org/10.1186/s13014-023-02236-1

Similar Items